Legal Representation
Attorney
Christie Baty Hudgins
USPTO Deadlines
Next Deadline
153 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 30, 2025
Extension Available
Until December 30, 2025
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 20, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 20, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 20, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 31, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 11, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 7, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 2, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jul 2, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 5, 2024 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Apr 5, 2024 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Apr 5, 2024 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Apr 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 6, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 5, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for gene therapy; pharmaceutical preparations that use genome editing to treat genetic, oncological, and immune system disorders and diseases
Additional Information
Design Mark
The mark consists of a stylized representation of a gene being inserted into the human genome, made of three columns of broken vertical lines in the colors light gray, dark gray, dark blue, and pink, with the pink element representing the inserted gene.
Color Claim
The color(s) light gray, dark gray, dark blue, and pink is/are claimed as a feature of the mark.
Classification
International Classes
005